https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
- Forums
- ASX - By Stock
- SPL
- If Viraleze 7 day treatment is competing with Paxlovid - who wins
If Viraleze 7 day treatment is competing with Paxlovid - who wins
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.6¢ |
Change
0.001(1.05%) |
Mkt cap ! $39.58M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.5¢ | $11.41K | 118.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 239840 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 239840 | 0.095 |
2 | 55000 | 0.094 |
2 | 239380 | 0.093 |
1 | 43260 | 0.092 |
4 | 24153 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 65000 | 1 |
0.100 | 119205 | 4 |
0.105 | 66531 | 4 |
0.110 | 39609 | 6 |
0.115 | 138531 | 6 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
LKE
Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
SPL (ASX) Chart |